With + 10% in 2012 and the same outlook by 2017, the aesthetic medicine market is showing insolent health, especially in Asia. That of breast implants was slowed down by the PIP affair.
France arrives in 9e position, just behind Brazil. But the world champions of aesthetic medicine are undoubtedly the South Koreans. Like Asia, this market is experiencing insolent growth and should grow by 14% per year by 2017.
All over the world, this sector is in good health. With an increase of 10% in 2012, it amounts to between 4.1 and 4.8 billion euros. And the specialists gathered in Paris for the European congress devoted to plastic surgeons and dermatologists (lmcas, International Master Course on Aging Skin) can rub their hands. In a difficult economic context, the visionaries of “youth medicine” are green: 7.1 billion euros in 2017 or 10% per year.
With the crisis raging in the southern countries, Europe is below the world average with 6.6% per year. The United States and Latin America are expected to grow by 9.2% and 10% respectively.
Injectables, botulinum toxins, fillers, remain the leading market and will grow by 10% on average by 2017. Laser and ultrasound should pick up with an average growth of 10.3% until 2017 .
The case of the fraudulent PIP implants is undoubtedly there. contributed, implantable breast prostheses have a more limited outlook of 5.2% per year by 2017. After a particularly delicate difficult year 2012: +1.9.
.